LabCorp(R) Scheduled to Present at The SG Cowen & Company Annual Healthcare Conference Mar 14, 2005 at 4:00 PM EST PDF Version BURLINGTON, N.C., March 14 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Executive Vice President for Corporate Affairs, Bradford T. Smith, is scheduled to speak at the SG Cowen & Company Healthcare Conference in Boston, MA on March 15, 2005 at 10:30 a.m. and 11:20 a.m. Eastern Time. A live audio webcast of the presentation will be available via the Company web site at www.labcorp.com . An archived replay of the audio webcast will be available. About LabCorp Laboratory Corporation of America(R) Holdings, an S&P 500 company with a BBB investment-grade credit rating, is a pioneer in commercializing new diagnostic technologies and the first in its industry to embrace genomic testing. With annual revenues of $3.1 billion in 2004, approximately 23,500 employees nationwide, and more than 220,000 clients, LabCorp offers over 4,400 clinical assays ranging from blood analyses to HIV and genomic testing. LabCorp combines its expertise in innovative clinical testing technology with its Centers of Excellence: The Center for Molecular Biology and Pathology, in Research Triangle Park, NC; National Genetics Institute, Inc. in Los Angeles, CA; ViroMed Laboratories, Inc. based in Minneapolis, MN; The Center for Esoteric Testing in Burlington, NC; DIANON Systems, Inc. based in Stratford, CT, and US LABS based in Irvine, CA. LabCorp clients include physicians, government agencies, managed care organizations, hospitals, clinical labs, and pharmaceutical companies. To learn more about our growing organization, visit our web site at: www.LabCorp.com . Each of the above forward-looking statements is subject to change based on various important factors, including without limitation, competitive actions in the marketplace and adverse actions of governmental and other third-party payors. Actual results could differ materially from those suggested by these forward-looking statements. Further information on potential factors that could affect LabCorp's financial results is included in the Company's Form 10-K for the year ended December 31, 2004 and subsequent SEC filings. SOURCE Laboratory Corporation of America Holdings -0- 03/14/2005 /CONTACT: Brad Hayes of Laboratory Corporation of America Holdings, +1-336-436-4602, or Shareholder Direct, +1-800-LAB-0401 / /Web site: http://www.labcorp.com / (LH) CO: Laboratory Corporation of America Holdings ST: North Carolina IN: HEA MTC BIO SU: CCA MAV LA-DL -- CLM049 -- 2011 03/14/2005 15:58 EST http://www.prnewswire.com
